LISA HARRELSON: Open Payments
NPI 1013636729 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 25 payments from 10 companies in 2025. Trend: 2023 $811 · 2024 $616 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $239 |
| Novo Nordisk Inc | 3 | $103 |
| ANI Pharmaceuticals, Inc. | 3 | $61 |
| ABBVIE INC. | 2 | $48 |
| Fresenius USA Marketing, Inc. | 2 | $45 |
| Travere Therapeutics, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: Fabhalta, Vanrafia, Ozempic, PURIFIED CORTROPHIN GEL, VRAYLAR, VELPHORO, SPRAVATO, LUPKYNIS.
Industry payments across PA — which companies pay providers there.
